Tc1/Tc2 imbalance in the peripheral blood of patients with recurrent genital herpes

2006 ◽  
Vol 26 (1) ◽  
pp. 145-147
Author(s):  
Deng Yunhua ◽  
Yang Dongliang ◽  
Chen Xingping ◽  
Chen Yinling
Keyword(s):  
Genital Herpes ◽  
Peripheral Blood ◽  
Recurrent Genital Herpes

Pathogenetic Therapy of Patients with Recurrent Genital Herpes

2020 ◽  
Vol 65 (5-6) ◽  
pp. 30-34
Author(s):  
L. L. Logvina ◽  
D. N. Bayram ◽  
Z. A. Kambachokova ◽  
F. V. Shavaeva ◽  
Z. S. Krymshokalova ◽  
...  
Keyword(s):  
Lipid Peroxidation ◽  
Blood Plasma ◽  
Genital Herpes ◽  
Antioxidant Defense ◽  
Clinical Manifestations ◽  
Complex Treatment ◽  
Herpesvirus Infection ◽  
Recurrent Genital Herpes ◽  
Complex Therapy ◽  
Pathogenetic Therapy

Evaluation of the effectiveness of aminophthalhydroside in the complex treatment of patients with recurrent genital herpes was carried out. The efficacy of the drug was assessed by clinical, biochemical, and immunological criteria. The inclusion of aminophthalhydrazide in the complex therapy of patients with recurrent herpesvirus infection led to an earlier relief of clinical manifestations of the disease, an increase in the relapse period, a decrease in lipid peroxidation products in the blood plasma, an increase in the content of antioxidant defense components, and correction of immunological disorders.

2017 European guidelines for the management of genital herpes

2017 ◽  
Vol 28 (14) ◽  
pp. 1366-1379 ◽  
Author(s):  
Rajul Patel ◽  
Oliver J Kennedy ◽  
Emily Clarke ◽  
Anna Geretti ◽  
Arvid Nilsen ◽  
...  
Keyword(s):  
Genital Herpes ◽  
Early Recognition ◽  
Recurrent Genital Herpes ◽  
Sexually Transmitted ◽  
European Guidelines ◽  
Duration Of Illness ◽  
Clinical Scenarios ◽  
Immunodeficiency Virus ◽  
Initiation Of Therapy

Genital herpes is one of the commonest sexually transmitted infections worldwide. Using the best available evidence, this guideline recommends strategies for diagnosis, management, and follow-up of the condition as well as for minimising transmission. Early recognition and initiation of therapy is key and may reduce the duration of illness or avoid hospitalisation with complications, including urinary retention, meningism, or severe systemic illness. The guideline covers a range of common clinical scenarios, such as recurrent genital herpes, infection during pregnancy, and co-infection with human immunodeficiency virus.

Treatment of recurrent genital herpes with topical alpha interferon gel combined with nonoxynol 9

1986 ◽  
Vol 15 (5) ◽  
pp. 989-994 ◽  
Author(s):  
Alvin E. Friedman-Kien ◽  
Richard J. Klein ◽  
Richard D. Glaser ◽  
Sharon M. Czelusniak
Keyword(s):  
Genital Herpes ◽  
Alpha Interferon ◽  
Recurrent Genital Herpes
Sign in / Sign up

Export Citation Format

Share Document